|
1
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garzon R, Fabbri M, Cimmino A, Calin GA
and Croce CM: MicroRNA expression and function in cancer. Trends
Mol Med. 12:580–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng Y: Principles of micro-RNA production
and maturation. Oncogene. 25:6156–6162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ahmed FE: Role of miRNA in carcinogenesis
and biomarker selection: a methodological view. Expert Rev Mol
Diagn. 7:569–603. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Croce CM: Oncogenes and cancer. N Engl J
Med. 358:502–511. 2008. View Article : Google Scholar
|
|
8
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar
|
|
9
|
Ebert MS and Sharp PA: MicroRNA sponges:
progress and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brown BD and Naldini L: Exploiting and
antagonizing microRNA regulation for therapeutic and experimental
applications. Nat Rev Genet. 10:578–585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kloosterman WP, Lagendijk AK, Ketting RF,
Moulton JD and Plasterk RH: Targeted inhibition of miRNA maturation
with morpholinos reveals a role for miR-375 in pancreatic islet
development. PLoS Biol. 5:e2032007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krützfeldt J, Rajewsky N, Braich R, et al:
Silencing of microRNAs in vivo with ‘antagomirs’. Nature.
438:685–689. 2005.
|
|
13
|
Park CY, Choi YS and McManus MT: Analysis
of microRNA knockouts in mice. Hum Mol Genet. 19:R169–R175. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 4:721–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barbato C, Ruberti F, Pieri M, et al:
MicroRNA-92 modulates K(+) Cl(−) co-transporter KCC2 expression in
cerebellar granule neurons. J Neurochem. 113:591–600.
2010.PubMed/NCBI
|
|
16
|
Huang J, Zhao L, Xing L and Chen D:
MicroRNA-204 regulates Runx2 protein expression and mesenchymal
progenitor cell differentiation. Stem Cells. 28:357–364.
2010.PubMed/NCBI
|
|
17
|
Bonci D, Coppola V, Musumeci M, et al: The
miR-15a-miR-16-1 cluster controls prostate cancer by targeting
multiple oncogenic activities. Nat Med. 14:1271–1277. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Valastyan S, Reinhardt F, Benaich N, et
al: A pleiotropically acting microRNA, miR-31, inhibits breast
cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Papapetrou EP, Korkola JE and Sadelain M:
A genetic strategy for single and combinatorial analysis of miRNA
function in mammalian hematopoietic stem cells. Stem Cells.
28:287–296. 2010.PubMed/NCBI
|
|
20
|
Gentner B, Schira G, Giustacchini A, et
al: Stable knockdown of microRNA in vivo by lentiviral vectors. Nat
Methods. 6:63–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Loya CM, Lu CS, Van Vactor D and Fulga TA:
Transgenic microRNA inhibition with spatiotemporal specificity in
intact organisms. Nat Methods. 6:897–903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Landgraf P, Rusu M, Sheridan R, et al: A
mammalian microRNA expression atlas based on small RNA library
sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jopling CL, Norman KL and Sarnow P:
Positive and negative modulation of viral and cellular mRNAs by
liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol.
71:369–376. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jopling CL: Regulation of hepatitis C
virus by microRNA-122. Biochem Soc Trans. 36:1220–1223. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Girard M, Jacquemin E, Munnich A, Lyonnet
S and Henrion-Caude A: miR-122, a paradigm for the role of
microRNAs in the liver. J Hepatol. 48:648–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gramantieri L, Ferracin M, Fornari F, et
al: Cyclin G1 is a target of miR-122a, a microRNA frequently
down-regulated in human hepatocellular carcinoma. Cancer Res.
67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma L, Liu J, Shen J, et al: Expression of
miR-122 mediated by adenoviral vector induces apoptosis and cell
cycle arrest of cancer cells. Cancer Biol Ther. 9:554–561. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bai S, Nasser MW, Wang B, et al:
MicroRNA-122 inhibits tumorigenic properties of hepatocellular
carcinoma cells and sensitizes these cells to sorafenib. J Biol
Chem. 284:32015–32027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang S, Qiu L, Yan X, et al: Loss of
microRNA 122 expression in patients with hepatitis B enhances
hepatitis B virus replication through cyclin G(1)-modulated P53
activity. Hepatology. 55:730–741. 2012. View Article : Google Scholar
|
|
31
|
Lin CJ, Gong HY, Tseng HC, Wang WL and Wu
JL: miR-122 targets an anti-apoptotic gene, Bcl-w, in human
hepatocellular carcinoma cell lines. Biochem Biophys Res Commun.
375:315–320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsai WC, Hsu PW, Lai TC, et al:
MicroRNA-122, a tumor suppressor microRNA that regulates
intrahepatic metastasis of hepatocellular carcinoma. Hepatology.
49:1571–1582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kutay H, Bai S, Datta J, et al:
Downregulation of miR-122 in the rodent and human hepatocellular
carcinomas. J Cell Biochem. 99:671–678. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sahu SC, O’Donnell MW Jr and Sprando RL:
Interactive toxicity of usnic acid and lipopolysaccharides in human
liver HepG2 cells. J Appl Toxicol. 32:739–749. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meister G, Landthaler M, Dorsett Y and
Tuschl T: Sequence-specific inhibition of microRNA- and
siRNA-induced RNA silencing. RNA. 10:544–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ørom UA, Kauppinen S and Lund AH:
LNA-modified oligonucleotides mediate specific inhibition of
microRNA function. Gene. 372:137–141. 2006.PubMed/NCBI
|
|
37
|
Davis S, Lollo B, Freier S and Esau C:
Improved targeting of miRNA with antisense oligonucleotides.
Nucleic Acids Res. 34:2294–2304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Obad S, dos Santos CO, Petri A, et al:
Silencing of microRNA families by seed-targeting tiny LNAs. Nat
Genet. 43:371–378. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Otaegi G, Pollock A and Sun T: An
optimized sponge for microrna miR-9 affects spinal motor neuron
development in vivo. Front Neurosci. 5:1462012. View Article : Google Scholar : PubMed/NCBI
|
